Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Not applicableStudy completedNCT04092491
What this trial is testing

Study of the IgA Repertoire During IgA Deposition Nephropathy.

Who this might be right for
Glomerulonephritis, IGA
University Hospital, Limoges 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05799287
What this trial is testing

Telitacicept for IgA Nephropathy (TELIGAN)

Who this might be right for
Primary IgA Nephropathy
RemeGen Co., Ltd. 318
Not applicableLooking for participantsNCT07074951
What this trial is testing

Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

Who this might be right for
Primary IgA-nephropathyHigh-riskCaucasians
St. Petersburg State Pavlov Medical University 240
Testing effectiveness (Phase 2)UnknownNCT03580291
What this trial is testing

Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Lingyun Sun 230
Testing effectiveness (Phase 2)Study completedNCT03945318
What this trial is testing

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 103
Testing effectiveness (Phase 2)Study completedNCT03124368
What this trial is testing

A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN

Who this might be right for
C3 GlomerulonephritisDense Deposit DiseaseC3 Glomerulopathy+2 more
Alexion Pharmaceuticals, Inc. 6
Not applicableUnknownNCT04805047
What this trial is testing

SodiUm Restriction by Behavioral Intervention

Who this might be right for
IgA Nephropathy
First Affiliated Hospital Xi'an Jiaotong University 142
Testing effectiveness (Phase 2)Study completedNCT06513338
What this trial is testing

Complement C5 mAb in the Treatment of Anti-GBM Disease

Who this might be right for
Autoimmune Diseases
Peking University First Hospital 16
Not applicableStudy completedNCT03880643
What this trial is testing

Rituximab in Refractory Primary Membranous Nephropathy

Who this might be right for
Glomerulonephritis, Membranous
Istanbul University 36
Testing effectiveness (Phase 2)UnknownNCT04846010
What this trial is testing

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

Who this might be right for
Sequelae of; InfectionPost Infection GlomerulonephritisPost-Infectious Peripheral Neuralgia+15 more
All Natural Medicine Clinic, LLC 2,000
Testing effectiveness (Phase 2)Study completedNCT00914524
What this trial is testing

Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy

Who this might be right for
Chronic GlomerulonephritisDiabetic Nephropathy
Daiichi Sankyo Co., Ltd. 49
Testing effectiveness (Phase 2)Study completedNCT05856760
What this trial is testing

Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN

Who this might be right for
Immunoglobulin A Nephropathy
Travere Therapeutics, Inc. 48
Large-scale testing (Phase 3)Study completedNCT02062684
What this trial is testing

BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration

Who this might be right for
IgA Nephropathy
Anthera Pharmaceuticals 57
Testing effectiveness (Phase 2)Ended earlyNCT04564339
What this trial is testing

Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Lupus NephritisImmunoglobulin A Nephropathy
Alexion Pharmaceuticals, Inc. 123
Not applicableStudy completedNCT01156428
What this trial is testing

Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease

Who this might be right for
ProteinuriaKidney InjuryChronic Kidney Disease
The Rogosin Institute 119
Not applicableUnknownNCT06245707
What this trial is testing

The Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous Nephropathy

Who this might be right for
Mild Cognitive ImpairmentIdiopathic Membranous Nephropathy
Beijing Friendship Hospital 2
Testing effectiveness (Phase 2)UnknownNCT02936375
What this trial is testing

The Iguratimod Effect on Lupus Nephritis (IGeLU)

Who this might be right for
Lupus Nephritis
RenJi Hospital 120
Large-scale testing (Phase 3)Looking for participantsNCT07390123
What this trial is testing

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Who this might be right for
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd. 370
Testing effectiveness (Phase 2)Looking for participantsNCT06090227
What this trial is testing

AMPK-activation by Metformin in FSGS: AMP-FSGS

Who this might be right for
Focal Segmental Glomerulosclerosis
Yale University 30
Next Page